Project cooperation
A vaccine against ETEC for both children in LMIC and travellers. SBH is currently preparing for the start of pivotal phase III trial
Author
We are a research-based specialty biopharma company determined to give people all over the world a longer and better life.
We are currently preparing the start of pivotal phase III trials and expect to the first vaccine preventing diarrhoea caused by ETEC in both endemic populations and travellers.
We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.
Area of Activities
Project cooperation
A vaccine against ETEC for both children in LMIC and travellers. SBH is currently preparing for the start of pivotal phase III trial